Hot Stocks: Brokerage view on Kotak Mahindra, Glenmark Pharma, Biocon and RIL 0 20.02.2024 07:53 Economictimes.indiatimes.com The risk-to-reward ratio is unfavourable at current levels. Earnings downgrades will continue due to a lack of new launches. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
